HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Feng Wang Selected Research

NADPH Oxidase 4

1/2022Oxidative Injury in Ischemic Stroke: A Focus on NADPH Oxidase 4.
1/2019NADPH oxidase 4 is correlated with gastric cancer progression and predicts a poor prognosis.
1/2018NADPH oxidase 4 regulates anoikis resistance of gastric cancer cells through the generation of reactive oxygen species and the induction of EGFR.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Feng Wang Research Topics

Disease

756Neoplasms (Cancer)
12/2024 - 01/2002
141Neoplasm Metastasis (Metastasis)
05/2024 - 03/2002
131Inflammation (Inflammations)
04/2024 - 06/2008
102Colorectal Neoplasms (Colorectal Cancer)
12/2024 - 08/2007
97Infections
04/2024 - 05/2002
81Stomach Neoplasms (Stomach Cancer)
12/2023 - 03/2006
67Breast Neoplasms (Breast Cancer)
03/2024 - 03/2002
65Carcinogenesis
04/2024 - 04/2010
63Hypoxia (Hypoxemia)
03/2024 - 11/2004
58Pancreatic Neoplasms (Pancreatic Cancer)
03/2024 - 01/2002
54Esophageal Squamous Cell Carcinoma
05/2024 - 07/2010
54Fibrosis (Cirrhosis)
04/2024 - 02/2011
52Prostatic Neoplasms (Prostate Cancer)
01/2024 - 12/2006
50Lung Neoplasms (Lung Cancer)
06/2023 - 08/2002
45Hepatocellular Carcinoma (Hepatoma)
05/2024 - 09/2006
43Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
04/2024 - 05/2007
43Carcinoma (Carcinomatosis)
12/2023 - 10/2003
42Stroke (Strokes)
03/2024 - 07/2004
41COVID-19
02/2024 - 01/2020
40Ischemic Stroke
03/2024 - 09/2004
39Atherosclerosis
01/2024 - 01/2010
38Insulin Resistance
09/2022 - 04/2002
35Glioma (Gliomas)
06/2023 - 07/2009
34Wounds and Injuries (Trauma)
11/2023 - 12/2002
32Lymphatic Metastasis
03/2024 - 08/2008
32Hypertension (High Blood Pressure)
01/2024 - 07/2004
32Type 2 Diabetes Mellitus (MODY)
01/2023 - 02/2003
30Reperfusion Injury
11/2023 - 10/2002
29Body Weight (Weight, Body)
04/2024 - 02/2011
29Adenocarcinoma
11/2023 - 05/2009
26Infarction (Infarctions)
03/2024 - 12/2006
26Pain (Aches)
01/2024 - 11/2008
26Necrosis
04/2023 - 03/2002
25Ischemia
06/2023 - 10/2002
25Tuberculosis (Tuberculoses)
01/2022 - 04/2006
23Brain Ischemia (Cerebral Ischemia)
10/2023 - 02/2011
22Alzheimer Disease (Alzheimer's Disease)
03/2024 - 12/2005
22Glioblastoma (Glioblastoma Multiforme)
12/2023 - 01/2012
22Obesity
01/2022 - 04/2002
21Cognitive Dysfunction
05/2024 - 12/2005
21Esophageal Neoplasms (Esophageal Cancer)
11/2023 - 03/2008
20Colonic Neoplasms (Colon Cancer)
01/2024 - 05/2009
19Hypertrophy
02/2024 - 05/2002
19Parkinson Disease (Parkinson's Disease)
04/2023 - 12/2008
18Hepatitis B
01/2024 - 07/2009
18Epilepsy (Aura)
10/2023 - 05/2010
18Cardiovascular Diseases (Cardiovascular Disease)
08/2023 - 09/2012
18Hemorrhage
03/2023 - 08/2013
17Urinary Bladder Neoplasms (Bladder Cancer)
03/2024 - 01/2017
17Pancreatitis
01/2024 - 01/2008
17Diabetic Nephropathies (Diabetic Nephropathy)
10/2023 - 05/2008
17Squamous Cell Carcinoma of Head and Neck
05/2023 - 06/2012

Drug/Important Bio-Agent (IBA)

274Proteins (Proteins, Gene)FDA Link
05/2024 - 05/2002
168Biomarkers (Surrogate Marker)IBA
04/2024 - 07/2006
77Messenger RNA (mRNA)IBA
05/2024 - 01/2002
67MicroRNAs (MicroRNA)IBA
01/2024 - 09/2011
65Glucose (Dextrose)FDA LinkGeneric
01/2024 - 12/2002
63Long Noncoding RNAIBA
06/2023 - 01/2014
61CytokinesIBA
01/2024 - 05/2002
56Small Interfering RNA (siRNA)IBA
11/2023 - 03/2006
52EnzymesIBA
04/2024 - 05/2005
46AntigensIBA
12/2023 - 09/2011
44DNA (Deoxyribonucleic Acid)IBA
04/2024 - 09/2006
43RNA (Ribonucleic Acid)IBA
02/2024 - 01/2002
42Therapeutic UsesIBA
03/2024 - 07/2008
36Peptides (Polypeptides)IBA
03/2024 - 05/2005
35LipidsIBA
11/2023 - 02/2006
34Circular RNAIBA
10/2023 - 01/2018
33Insulin (Novolin)FDA Link
11/2023 - 04/2002
33LigandsIBA
08/2023 - 09/2003
31Immune Checkpoint InhibitorsIBA
03/2024 - 04/2017
31Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
03/2024 - 03/2002
30Reactive Oxygen Species (Oxygen Radicals)IBA
02/2024 - 05/2009
26Indicators and Reagents (Reagents)IBA
03/2024 - 02/2007
25AntibodiesIBA
01/2023 - 01/2004
24CateninsIBA
12/2024 - 08/2009
24ErbB Receptors (EGF Receptor)IBA
01/2024 - 03/2004
23Anti-Bacterial Agents (Antibiotics)IBA
10/2023 - 06/2002
23Phosphotransferases (Kinase)IBA
11/2022 - 05/2005
22CollagenIBA
01/2024 - 12/2006
21Cisplatin (Platino)FDA LinkGeneric
05/2024 - 02/2012
21Oxygen (Dioxygen)IBA
01/2024 - 07/2009
21Doxorubicin (Adriamycin)FDA LinkGeneric
11/2023 - 05/2011
21Transcription Factors (Transcription Factor)IBA
10/2023 - 07/2009
21Hepatitis B Surface Antigens (HBsAg)FDA Link
12/2022 - 07/2004
20Interleukin-6 (Interleukin 6)IBA
09/2023 - 11/2012
19gallium 68 PSMA-11IBA
12/2023 - 02/2017
18AcidsIBA
01/2024 - 06/2008
18Cadherins (E-Cadherin)IBA
01/2024 - 01/2006
18LipopolysaccharidesIBA
06/2023 - 01/2014
18AlbuminsIBA
01/2023 - 09/2007
17salicylhydroxamic acid (SHAM)IBA
01/2024 - 10/2002
17Fatty Acids (Saturated Fatty Acids)IBA
11/2022 - 08/2009
17Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2022 - 01/2002

Therapy/Procedure

316Therapeutics
05/2024 - 01/2004
116Drug Therapy (Chemotherapy)
05/2024 - 09/2003
55Immunotherapy
04/2024 - 10/2014
42Radiotherapy
11/2023 - 01/2012
21Stents
01/2022 - 02/2006
16Aftercare (After-Treatment)
05/2024 - 06/2006